Filing Details
- Accession Number:
- 0000899243-20-007256
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-05 18:52:19
- Reporting Period:
- 2020-03-03
- Accepted Time:
- 2020-03-05 18:52:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1571498 | Epizyme Inc. | EPZM | Pharmaceutical Preparations (2834) | 261349956 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1766032 | Joseph Beaulieu | C/O Epizyme, Inc., 400 Technology Square Cambridge MA 02139 | Corporate Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-03-03 | 996 | $22.18 | 3,617 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The reporting person acquired 996 shares of Common Stock under the Issuer's 2013 Employee Stock Purchase Plan on February 28, 2020.
Billionaire Hedge Funds
